Palvella Therapeutics (PVLA) EBIT Margin Growth (5y) (2019 - 2024)
Palvella Therapeutics (PVLA) EBIT Margin Growth (5y) (2019 - 2024) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Palvella Therapeutics | 2.25 Bn | 1.93 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2024 | -319,385.00 |
| Dec 31, 2023 | 162,993.00 |
| Sep 30, 2023 | 3,303.00 |
| Jun 30, 2023 | 2,947.00 |
| Mar 31, 2023 | -57,574.00 |
| Dec 31, 2022 | -844,377.00 |
| Sep 30, 2022 | -458,427.00 |
| Jun 30, 2022 | -493,502.00 |
| Mar 31, 2022 | 52,826.00 |
| Dec 31, 2021 | 10,464.00 |
| Sep 30, 2021 | 31,837.00 |
| Jun 30, 2021 | -170,961.00 |
| Mar 31, 2021 | 31,248.00 |
| Dec 31, 2020 | 47,100.00 |
| Sep 30, 2020 | 43,156.00 |
| Jun 30, 2020 | 216,307.00 |
| Mar 31, 2020 | 167,174.00 |
| Sep 30, 2019 | 23,350.00 |
| Jun 30, 2019 | -6,322.00 |